News
Discover why BeOne Medicines (BEIGF) is a strong Buy with growth driven by Brukinsa, Tevimbra, and a promising oncology ...
With a distribution agreement in place and an option to acquire Contego Medical, Medtronic’s peripheral vascular division ki ...
Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next ...
FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...
Phase 1 data shows encouraging safety and niche efficacy. Click here to find out why I maintain a buy rating for SDGR stock.
The family of accused Gilgo Beach serial killer Rex Heuermann has gotten a helping hand from an unexpected source: The ...
On June 12, Keymed Biosciences Inc. (HKEX: 02162) announced that Prof. Jun Shi's research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences ...
During a live event, Danielle M. Brander, MD, discussed use of zanubrutinib in high-risk chronic lymphocytic leukemia.
An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...
Kerri Rawson, daughter of BTK Killer Dennis Rader, met with the family of accused Gilgo Beach serial killer Rex Heuermann in ...
The aberrant activation of B-cells has been implicated in several types of cancers and hematological disorders. BTK and PI3Kδ are kinases responsible for B-cell signal transduction, and inhibitors of ...
During a live event, John S. Renshaw, MD, and other oncologists discussed various trials of novel regimens for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results